Keyphrases
Membrane Channels
100%
Plasma Membrane
100%
Necrosis
100%
Immunogenic
100%
Transient Receptor Potential Melastatin 2 (TRPM2)
100%
Unfolded Protein Response
36%
Hyperactivity
27%
Cancer Cells
18%
Cell Death
18%
Anticancer Therapy
18%
Sodium
9%
Immune Cells
9%
Negative Selection
9%
Breast Tumor
9%
Cell Volume
9%
Cell Swelling
9%
Osmotic Stress
9%
Cancer Therapy
9%
Associated Genes
9%
Anticancer Activity
9%
Cell Release
9%
Cell Depletion
9%
Immune Activation
9%
Activated Macrophages
9%
Cancer Immunotherapy
9%
Re-expression
9%
Necrotic Cell Death
9%
Emerging Therapies
9%
CRISPR-Cas9 Screen
9%
Initial Activation
9%
CRISPR Interference (CRISPRi)
9%
Molecular Drivers
9%
Damage-associated Molecular Patterns
9%
Monocyte Migration
9%
Calcium-activated
9%
Immunotherapy Efficacy
9%
TRPM4
9%
Sodium Influx
9%
Preclinical Agents
9%
Medicine and Dentistry
Cell Membrane
100%
Necrosis
100%
Receptor Potential
100%
Membrane Channel
100%
Unfolded Protein Response
36%
Cell Death
27%
Hyperactivation
27%
Cancer Treatment
18%
Cancer Cell
18%
Clustered Regularly Interspaced Short Palindromic Repeat
18%
Adenosine Triphosphate
18%
Breast Tumor
9%
Macrophage
9%
Isotopes of Calcium
9%
Downregulation
9%
Cas9
9%
Cancer Therapy
9%
Immunocompetent Cell
9%
Antineoplastic Activity
9%
Immunotherapy
9%
Cell Swelling
9%
Cancer Immunotherapy
9%
Sodium Transport
9%
Osmotic Stress
9%
TRPM4
9%
Biochemistry, Genetics and Molecular Biology
Cell Membrane
100%
Membrane Channel
100%
Receptor Potential
100%
Unfolded Protein Response
36%
Cell Death
27%
Adenosine Triphosphate
18%
Cancer Cell
18%
Anticancer
18%
Macrophage
9%
Downregulation
9%
Immunocompetent Cell
9%
Cell Volume
9%
CRISPR
9%
Cell Swelling
9%
Osmotic Stress
9%
Antineoplastic Activity
9%
CRISPR/Cas9
9%
Sodium Transport
9%
Cancer Immunotherapy
9%
TRPM4
9%
Immunology and Microbiology
Cell Membrane
100%
Membrane Channel
100%
Receptor Potential
100%
Unfolded Protein Response
36%
Cell Death
27%
Cancer Cell
18%
Macrophage
9%
Immunotherapy
9%
Immunocompetent Cell
9%
Cell Volume
9%
Antineoplastic Activity
9%
CRISPR/Cas9
9%
Osmotic Stress
9%
Downregulation
9%
Clustered Regularly Interspaced Short Palindromic Repeat
9%
Cancer Immunotherapy
9%
Sodium Transport
9%
Cell Swelling
9%
Pharmacology, Toxicology and Pharmaceutical Science
Necrosis
100%
Transient Receptor Potential Channel M
100%
Receptor
90%
Malignant Neoplasm
36%
Immunotherapy
18%
Adenosine Triphosphate
18%
Breast Tumor
9%